Why Vono
Vonoprazan, a novel class of Potassium Competitive Acid Blocker has been introduced in the space of Anti-peptic ulcerants post 3 long decades of PPI existence as the best alternative. This superior molecule promises to be the future with its key attributes of 24-hour pH > 4 holding time ratio, peak action with its first dose, and immediate symptomatic relief & no restriction of mealtime dosing for best patient outcomes. Dr. Reddys who has been at the forefront in Gastroenterology therapy are among the first few top Indian Pharma Companies to launch the patented molecule Vono ( Vonoprazan) along with a non-exclusive patent licensing agreement with manufacturers to commercialize Vono (Vonoprazan) in India.
Gastro
CYP2C19 Polymorphism: PPI Efficacy vs. Vonoprazan
button
button
Gastro
Recognizing The Novel Diagnostic Tools for H. pylori Infection
Accurate Diagnosis of H. pylori: Novel Tools You Should Know About
Recognizing The Novel Diagnostic Tools for H. pylori Infection
Accurate Diagnosis of H. pylori: Novel Tools You Should Know Aboutbutton
Gastro
Recognizing The Novel Diagnostic Tools for H. pylori Infection
Accurate Diagnosis of H. pylori: Novel Tools You Should Know About
button
Gastro
Are Your Patients Protected? The Hidden Risks of NSAID Therapy
Guard the Gut: NSAIDs Edition
Are Your Patients Protected? The Hidden Risks of NSAID Therapy
Guard the Gut: NSAIDs Editionbutton
button
Gastro
Recognizing the Two-Way Interconnections Between GERD and Essential Hypertension
GERD and High Blood Pressure: A Vicious Cycle?
Recognizing the Two-Way Interconnections Between GERD and Essential Hypertension
GERD and High Blood Pressure: A Vicious Cycle?button
Gastro
Recognizing the Two-Way Interconnections Between GERD and Essential Hypertension
GERD and High Blood Pressure: A Vicious Cycle?
button
Gastro
+ 1
Balancing Act: Aspirin and Clopidogrel Cut Heart Risks But Raise GI Complications!
Heart Meds Cut Risks, Spark GI Issues Now!
Balancing Act: Aspirin and Clopidogrel Cut Heart Risks But Raise GI Complications!
Heart Meds Cut Risks, Spark GI Issues Now!button
Gastro , Cardiac
Balancing Act: Aspirin and Clopidogrel Cut Heart Risks But Raise GI Complications!
Heart Meds Cut Risks, Spark GI Issues Now!
button
Gastro
+ 1
Identifying the Predictors of GIB in Patients on DAPT After PCI
Unlock DAPT Risk Post-PCI: Key Predictors
Identifying the Predictors of GIB in Patients on DAPT After PCI
Unlock DAPT Risk Post-PCI: Key Predictorsbutton
Gastro , Cardiac
Identifying the Predictors of GIB in Patients on DAPT After PCI
Unlock DAPT Risk Post-PCI: Key Predictors
button
Gastro
+ 1
NSAIDs: Augmenting the Risk of Gastric Complications
NSAIDs: Boosting Gastric Risk Awareness
NSAIDs: Augmenting the Risk of Gastric Complications
NSAIDs: Boosting Gastric Risk Awarenessbutton
Gastro , Cardiac
NSAIDs: Augmenting the Risk of Gastric Complications
NSAIDs: Boosting Gastric Risk Awareness
button
Gastro
+ 1
Deciphering the Prevalence and Clinical Traits of FED in Patients With PPI-Unresponsive Reflux Symptoms
Breakthrough: Key Clinical Traits of FED Revealed
Deciphering the Prevalence and Clinical Traits of FED in Patients With PPI-Unresponsive Reflux Symptoms
Breakthrough: Key Clinical Traits of FED Revealedbutton
Gastro , Gastro Intestinal
Deciphering the Prevalence and Clinical Traits of FED in Patients With PPI-Unresponsive Reflux Symptoms
Breakthrough: Key Clinical Traits of FED Revealed
button